Mergers and Acquisitions


Glaukos and DWTI announce development agreement

By Maggie Lynch

Glaukos Pharmaceutical, an ophthalmic medical technology and pharmaceutical company, and D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company, have announced an agreement.

GettyImages: Devonyu

Lundbeck to buy Prexton in potential $1bn+ deal

By Staff Reporter

The Danish drugmaker says it will take responsibility for commercial manufacturing after acquiring Parkinson’s disease candidate foliglurax in a deal worth up to €905m ($1.1bn).

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization. (Image: iStock/macgyverhh)

AMRI set to be acquired by private equity

By Melissa Fassbender

Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.

The merger will seeks to strengthen Pfizer's inflammation and immunology business.(Image: iStock/Kritchanut)

Pfizer, Anacor enter into merger agreement

By Melissa Fassbender

Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for approximately $5.2bn.